A Phase 4 interventional study of Dexamethasone 4mg and Dexamethasone 8 mg in Diabetes Mellitus and Hyperglycemia, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Assiut University · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Diabetes Mellitus by Assiut University — 21 open to participants now, 21 under way, none of them phase 3. Diabetes Mellitus · Assiut University.
Among the 33 studies in Diabetes Mellitus by Assiut University, this one is one of 7 that started in 2026, is one of 2 in phase 4, reaches primary completion later than 18 of the 20 other live ones, and was the 33rd registered.
8,293 studies on the registry are indexed under Diabetes Mellitus; 1,072 are open to participants now.
Browse Diabetes Mellitus studies →21 of the 33 studies in Diabetes Mellitus by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University · Sites in Egypt
Assiut University · Sites in Egypt
Assiut University
Ages 18+
Assiut University
Ages 18+
Assiut University
Ages 18+
By country, each count listing its studies:
Of the 648 Diabetes Mellitus studies recruiting now, 357 (55%) set no upper age limit and 195 (30%) stop at 75 or younger; 88 take children under 18; 182 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 7 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 150 is above the median of 80 across 6,025 interventional studies indexed under Diabetes Mellitus.
Median enrollment 110 across the 5 interventional studies, 108 across the 28 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,088 studies on the registry; 2,185 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
8 of the studies in Diabetes Mellitus by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07306884Assiut UniversityNeurophysiological, Autonomic, and Sonographic Assessment of Diabetic Peripheral Neuropathy | 2027-01 |
| NCT07343648Assiut UniversityAssessment of Antithyroglobulin Antibody Levels Among Diabetic Patients | 2027-02 |
| NCT07204782Assiut UniversityCardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize | 2027-04-01 |
| NCT07821814Assiut UniversityLeukocyte Glucose Index and Severity of Diabetic Ketoacidosis | 2027-09-10 |
| NCT07799727Assiut UniversityCentral Venous vs Arterial Blood Gas and CO2 Gap in Critically Ill Patients With and Without Diabetes | 2027-10 |
Add all 8 to your calendar (.ics) → With an account.
Among the 33 studies in Diabetes Mellitus by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized double-blind controlled trial aims to compare the effects of two different doses of intraoperative intravenous dexamethasone (4 mg versus 8 mg) versus placebo on perioperative glycemic response in adult patients with diabetes mellitus undergoing laparoscopic cholecystectomy.
Diabetes mellitus is a common comorbidity in patients undergoing surgery. Perioperative hyperglycemia is associated with increased morbidity. Dexamethasone is frequently administered intraoperatively for its antiemetic and anti-inflammatory effects, but it can cause hyperglycemia.
This randomized double-blind trial will allocate adult patients with established diabetes mellitus scheduled for elective laparoscopic cholecystectomy into three groups: Group I (4 mg dexamethasone), Group II (8 mg dexamethasone), and Group III (placebo). Blood glucose will be measured at predefined time points using a glucometer. The primary outcome is the maximum recorded perioperative blood glucose concentration within 24 hours after dexamethasone administration.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive 4 mg of intravenous dexamethasone diluted in 0.9% normal saline to 5 mL, administered intravenously over 30 seconds.
Drug: Dexamethasone 4mg
Patients will receive 8 mg of intravenous dexamethasone diluted in 0.9% normal saline to 5 mL, administered intravenously over 30 seconds.
Drug: Dexamethasone 8 mg
Patients will receive an equivalent volume of 0.9% normal saline intravenously as placebo.
Drug: Placebo (0.9% Normal Saline)
Intravenous 4 mg dexamethasone diluted in 0.9% normal saline to 5 mL, administered over 30 seconds.
Also known as: Dexamethasone
Intravenous 8 mg dexamethasone diluted in 0.9% normal saline to 5 mL, administered over 30 seconds.
Also known as: Dexamethasone
Equivalent volume of 0.9% normal saline intravenously.
Also known as: Placebo
Maximum Perioperative Blood Glucose Concentration
Maximum recorded perioperative blood glucose concentration in mg/dL within 24 hours after dexamethasone administration, measured by finger-prick capillary blood glucose using a glucometer.
Time frame: At 24 hours
Time to Peak Blood Glucose Concentration
Mean time in hours from dexamethasone administration to peak blood glucose concentration.
Time frame: At 24 hours
Proportion of Patients Developing Hyperglycemia
Proportion of patients developing blood glucose \> 180 mg/dL.
Time frame: At 24 hours
Proportion of Patients Developing Severe Hyperglycemia
Proportion of patients developing blood glucose \> 200 mg/dL or \> 250 mg/dL.
Time frame: At 24 hours
Requirement for Rescue Insulin
Proportion of patients requiring rescue insulin during the first 24 postoperative hours.
Time frame: At 24 hours
Incidence of Hypoglycemia
Proportion of patients developing blood glucose \< 70 mg/dL.
Time frame: At 24 hours
Postoperative Nausea and Vomiting
Incidence of postoperative nausea and vomiting.
Time frame: At 24 hours
Surgical Site Infection
Incidence of surgical site infection.
Time frame: At 30 days
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.
Of 149 non-industry phase 4 interventional studies under Diabetes Mellitus, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 12 months is below that.
Counting every sponsor, half of 197 studies reached it within 24 months; a quarter within 13 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.